Bausch Health Companies | VRX - Equity Capital And Reserves

Stock Price
7.01
Daily Change
-0.10 -1.41%
Monthly
-13.56%
Yearly
-30.11%
Q1 Forecast
6.65

Bausch Health Companies reported $-554M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Amgen USD 8.66B 961M Dec/2025
ANI Pharmaceuticals USD 540.72M 34.91M Dec/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bausch Health Companies USD -554M 910M Dec/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 647.8M 15.9M Dec/2025
Danaher USD 52.53B 1.46B Dec/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 26.54B 2.74B Dec/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Pacira USD 693.11M 34.1M Dec/2025
Perrigo USD 2.94B 1.51B Dec/2025
Phibro Animal Health USD 332.36M 20.68M Dec/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Supernus Pharmaceuticals USD 1.06B 12.05M Dec/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Zoetis USD 3.33B 2.07B Dec/2025